||1. Ao, Z.H., et al., Niuchangchih (Antrodia camphorata) and its potential in treating liver diseases. J Ethnopharmacol, 2009. 121(2): p. 194-212.|
2. Phuong do, T., et al., Inhibitory effects of antrodins A-E from Antrodia cinnamomea and their metabolites on hepatitis C virus protease. Phytother Res, 2009. 23(4): p. 582-4.
3. Corvinus, F.M., et al., Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia, 2005. 7(6): p. 545-55.
4. Levy, D.E. and C.-k. Lee, What does Stat3 do? J Clin Invest, 2002. 109(9): p. 1143-1148.
5. Scheidereit, C., IκB kinase complexes: gateways to NF-κB activation and transcription. Oncogene, 2006. 25(51): p. 6685-6705.
6. Klein, U. and S. Ghosh, The Two Faces of NF-ºB Signaling in Cancer Development and Therapy. Cancer Cell, 2011. 20(5): p. 556-558.
7. Kim, J., Y.-N. Cha, and Y.-J. Surh, A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2010. 690(1–2): p. 12-23.
8. Akira, S. and K. Takeda, Toll-like receptor signalling. Nat Rev Immunol, 2004. 4(7): p. 499-511.
9. Montagut, C. and J. Settleman, Targeting the RAF-MEK-ERK pathway in cancer therapy. Cancer Lett, 2009. 283(2): p. 125-34.
10. Zhang, W. and H.T. Liu, MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res, 2002. 12(1): p. 9-18.
11. Wickenden, J.A. and C.J. Watson, Key signalling nodes in mammary gland development and cancer. Signalling downstream of PI3 kinase in mammary epithelium: a play in 3 Akts. Breast Cancer Res, 2010. 12(2): p. 202.
12. Meulmeester, E. and P. ten Dijke, The dynamic roles of TGF-β in cancer. The Journal of Pathology, 2011. 223(2): p. 206-219.
13. Eivers, E., L.C. Fuentealba, and E.M. De Robertis, Integrating positional information at the level of Smad1/5/8. Current Opinion in Genetics & Development, 2008. 18(4): p. 304-310.
14. Nohe, A., et al., Signal transduction of bone morphogenetic protein receptors. Cellular Signalling, 2004. 16(3): p. 291-299.
15. Dahmani, R., P.-A. Just, and C. Perret, The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology, 2011. 35(11): p. 709-713.
16. Klaus, A. and W. Birchmeier, Wnt signalling and its impact on development and cancer. Nat Rev Cancer, 2008. 8(5): p. 387-98.
17. Oving, I.M. and H.C. Clevers, Molecular causes of colon cancer. European Journal of Clinical Investigation, 2002. 32(6): p. 448-457.
18. Chang, C.-y., et al., The Metabolic Regulator ERR±, a Downstream Target of HER2/IGF-1R, as a Therapeutic Target in Breast Cancer. Cancer Cell, 2011. 20(4): p. 500-510.
19. Stormshak, F. and C.V. Bishop, BOARD-INVITED REVIEW: Estrogen and progesterone signaling: Genomic and nongenomic actions in domestic ruminants. Journal of Animal Science, 2008. 86(2): p. 299-315.
20. Adams, J.S. and M. Hewison, Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract End Met, 2008. 4(2): p. 80-90.
21. White, J.H., Vitamin D Signaling, Infectious Diseases, and Regulation of Innate Immunity. Infection and Immunity, 2008. 76(9): p. 3837-3843.
22. Yang, H.-L., et al., Anti-metastatic activities of Antrodia camphorata against human breast cancer cells mediated through suppression of the MAPK signaling pathway. Food and Chemical Toxicology, 2011. 49(1): p. 290-298.
23. Rao, Y.K., et al., Identification of Antrocin from Antrodia camphorata as a Selective and Novel Class of Small Molecule Inhibitor of Akt/mTOR Signaling in Metastatic Breast Cancer MDA-MB-231 Cells. Chem Res Toxicol, 2010. 24(2): p. 238-245.